Jennifer helps clients in the pharmaceutical, personal care product and consumer goods sectors protect their business interests and reputations when facing high-stakes product liability litigation. 

A strategist with experience defending against innovator liability claims and other novel theories, Jennifer has served as lead counsel in multidistrict litigation as well as individual cases involving asthma, antiemetic, anti-seizure and weight loss medications, among other prescription drugs. In this capacity, she has authored Daubert briefs on general- and specific-causation in addition to defending experts from Daubert challenges and mounting such challenges against opposing experts. 

Jennifer also conducts in-depth risk assessments for clients, enabling them to get ahead of the product liability curve. She has a particular interest in federal preemption as it relates to pharmaceutical products and has monitored legal developments in this area. 

Representative Matters

Multidistrict Litigation. Lead counsel representing one of the world’s largest pharmaceutical manufacturers in multidistrict litigation alleging that antiemetic medication can cause birth defects.

Multidistrict Litigation. Drafted Daubert briefing and other motions in pharmaceutical multidistrict litigation alleging that anti-seizure medications cause suicidal thinking and completed suicide.

Multidistrict Litigation. Worked up bellwether cases in large pharmaceutical multidistrict litigation alleging that statins cause diabetes, before grant of summary judgment.

Coordinated State Court Litigation. Deposed dozens of plaintiffs and healthcare providers in large pharmaceutical state court coordinated litigation and obtained concessions leading to dismissal of cases.

Pharmaceutical Product Liability Litigation. Obtained stay of discovery for more than a year and dismissal with prejudice of lawsuit involving weight loss medication.

Product Liability Litigation. Represented the largest domestic manufacturer of plastic consumer gasoline containers in numerous cases alleging injuries from misuse of the containers.

Pro Bono. Handles juvenile criminal matters, guardianships, and adoptions of children with special medical needs.


Publications

Kevin Ong, Michael Frobergh, Jennifer Stevenson and John Constance, Postmarket Surveillance: The Truth Is Never Simple (Part 3 - Legal Issues)Medical Device and Diagnostic Industry, December 19, 2016

Kevin Ong, Michael Frobergh, Jennifer Stevenson and John Constance, Postmarket Surveillance: The Truth Is Never Simple (Part 2 - Manufacturer Considerations)Medical Device and Diagnostic Industry, December 16, 2016

Kevin Ong, Michael Frobergh, Jennifer Stevenson and John Constance, Postmarket Surveillance: The Truth Is Never Simple (Part 1 - Regulatory Requirements and Data Sources), Medical Device and Diagnostic Industry, December 13, 2016

Jennifer Stevenson and James Muehlberger, How To Fight The Rising Tide Of Cosmetic Class Actions, Law360, June 3, 2014. 

Lori McGroder and Jennifer Stevenson, Cosmetics Under Fire: Tips to Avoid FDA Scrutiny, Law360, Nov. 30. 2012. 

Scott W. Sayler and Jennifer M. Stevenson, Ten Keys to Successfully Defending Mass Tort Products Liability Litigation (Association of Defense Trial Attorneys 2007).

Scott W. Sayler and Jennifer M. Stevenson, Kansas Section, Multi-National and Multi-State Extraordinary Damages Survey (International Association of Defense Counsel 2006).

Presentations

Jennifer Stevenson and Jessica Benson Cox, "Ensuring Labeling Compliance and Assessing Impact of Labeling on Product Liability Litigation," American Conference Institute's 8th Annual Summit on Biosimilars, New York City, New York, June 2017.

Lori McGroder and Jennifer Stevenson, "Things I Wish I Knew About Depositions When I Started Practicing," Kansas Association of Defense Counsel Annual Conference (Kansas City, Missouri), Dec. 2013.